PMID- 12227494 OWN - NLM STAT- MEDLINE DCOM- 20021118 LR - 20191025 IS - 1343-4934 (Print) IS - 1343-4934 (Linking) VI - 44 IP - 2 DP - 2002 Jun TI - Behavior of HO-1-N-1, buccal mucosa carcinoma derived cells, on [Ca2+]i responses to stimulants. PG - 103-8 AB - Buccal mucosa carcinoma-derived cell line, HO-1-N-1, epithelial-like cells, was obtained in order to investigate the characteristics of oral cancer cells and examine the [Ca2+]i responses to stimulants, such as bradykinin (BK), histamine (HIST), thapsigargin (TG), epidermal growth factor (EGF) and transforming growth factor alpha (TGF alpha ). Intracellular Ca2+ influx was observed by all stimulants that enhanced the [Ca2+]i response. However, intracellular Ca2+ release was not observed in response to growth factors. The [Ca2+]i response of BK (100 nM) was inhibited by 10 micro M of the BKB2 antagonist, D-Arg-[Hyp3, Thi5,8, D-Phe7]-BK, and HIST (1 mM) was completely inhibited by 100 nM of the H1 antagonist, (+)-chlorpheniramine, in the presence and absence of extracellular Ca2+ (1.5 mM). FAU - Arai, Takafumi AU - Arai T AD - Department of Pharmacology, Nihon University School of Dentistry at Matsudo, Chiba, Japan. FAU - Matsumoto, Hiroko AU - Matsumoto H FAU - Akimoto, Yoshiaki AU - Akimoto Y FAU - Nishimura, Hitoshi AU - Nishimura H FAU - Ono, Makiko AU - Ono M FAU - Fujii, Akira AU - Fujii A LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Japan TA - J Oral Sci JT - Journal of oral science JID - 9808942 RN - 0 (Histamine H1 Antagonists) RN - 0 (Receptors, Cell Surface) RN - 0 (Transforming Growth Factor alpha) RN - 62229-50-9 (Epidermal Growth Factor) RN - 67526-95-8 (Thapsigargin) RN - 820484N8I3 (Histamine) RN - S8TIM42R2W (Bradykinin) RN - SY7Q814VUP (Calcium) SB - IM MH - Bradykinin/antagonists & inhibitors/pharmacology MH - Calcium/*metabolism MH - Calcium Signaling/*drug effects MH - Carcinoma/*metabolism/pathology MH - Epidermal Growth Factor/pharmacology MH - Epithelial Cells/drug effects/*metabolism MH - Histamine/pharmacology MH - Histamine H1 Antagonists/pharmacology MH - Humans MH - Mouth Mucosa/pathology MH - Mouth Neoplasms/*metabolism/pathology MH - Receptors, Cell Surface/metabolism MH - Stimulation, Chemical MH - Thapsigargin/pharmacology MH - Transforming Growth Factor alpha/pharmacology MH - Tumor Cells, Cultured/drug effects/*metabolism EDAT- 2002/09/14 10:00 MHDA- 2002/11/26 04:00 CRDT- 2002/09/14 10:00 PHST- 2002/09/14 10:00 [pubmed] PHST- 2002/11/26 04:00 [medline] PHST- 2002/09/14 10:00 [entrez] AID - 10.2334/josnusd.44.103 [doi] PST - ppublish SO - J Oral Sci. 2002 Jun;44(2):103-8. doi: 10.2334/josnusd.44.103.